Association of hematological parameters with obesity-induced inflammation among young females in Ahvaz, South-West of Iran
Protective effect of thymoquinone, the main component of, against diazinon cardio-toxicity in rats
Rodent studies have shown that treatment with liraglutide or once-weekly exenatide is associated with thyroid C-cell proliferation and the formation of thyroid C-cell tumors ( Therefore, the US Food and Drug Administration (FDA) prohibits these therapies for patients with an individual or family history of medullary thyroid carcinoma (MTC) or patients with multiple endocrine neoplasia syndrome type 2 (MEN2)
Day 20 : Higher doses (50mg and 100mg) maintain results well
If you notice side effects after beginning with a low dosage, increasing your dosage is not recommended
For example, the follow-up up to 5 years in Kornelius 2024, and the study by Reaney 2013 lasted 24 months